Initial Therapeutics uses 8 technology products and services including Google Analytics, cdnjs, Google Hosted Libraries, and more. Explore Initial Therapeutics's tech stack below.
| Initial Therapeutics Email Formats | Percentage |
| FLast@initialtx.com | 45% |
| First@initialtx.com | 5% |
| FLast@initialtx.com | 45% |
| First@initialtx.com | 5% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages. Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
Company Overview
Funding & FinancialsInitial Therapeutics has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on May 01, 2023 in the amount of $75M.
Initial Therapeutics's revenue is in the range of $10M
Funding & FinancialsInitial Therapeutics has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on May 01, 2023 in the amount of $75M.
Initial Therapeutics's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com